临床医学工程2024，Vol.31Issue(2)：201-202,2.DOI:10.3969/j.issn.1674-4659.2024.02.0201
化疗与贝伐珠单抗联合治疗晚期非小细胞肺癌的效果与安全性分析
Analysis on the Efficacy and Safety of Chemotherapy Combined with Bevacizumab in the Treatment of Advanced Non-Small Cell Lung Cancer
郭丽芳 1周建华1
作者信息
- 1. 郑州大学第二附属医院药学部,河南郑州 450003
- 折叠
摘要
Abstract
Objective To analyze the effect and safety of chemotherapy combined with bevacizumab in the treatment of advanced non-small cell lung cancer(NSCLC).Methods 90 patients with advanced NSCLC were randomly divided into two groups.The control group was given conventional chemotherapy,and the observation group was treated with bevacizumab on the basis of the control group.The treatment effect and safety were compared between the two groups.Results After treatment,the total effective rate of treatment in the observation group was higher than that in the control group,and the levels of serum CEA,CA125 and VEGF were lower than those in the control group(P<0.05).No statistical difference was found in the incidences of adverse reactions between the two groups(P>0.05).Conclusions Chemotherapy combined with bevacizumab in the treatment of advanced NSCLC has significant effect and high safety.关键词
晚期非小细胞肺癌/化疗/贝伐珠单抗/疗效/安全性Key words
Advanced non-small cell lung cancer/Chemotherapy/Bevacizumab/Efficacy/Safety分类
医药卫生引用本文复制引用
郭丽芳,周建华..化疗与贝伐珠单抗联合治疗晚期非小细胞肺癌的效果与安全性分析[J].临床医学工程,2024,31(2):201-202,2.
